TWO · Healthcare

Andros Pharmaceuticals Co.,Ltd (6917)

Biotechnology

Andros Pharmaceuticals Co.,Ltd (6917) is listed on TWO in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 6917

P/E ratio

18.00

Andros Pharmaceuticals Co.,Ltd (6917) — FAQ

What is 6917's P/E ratio?

The price-to-earnings (P/E) ratio for Andros Pharmaceuticals Co.,Ltd (6917) is 18.00 (data as of 2026-03-23).

Does Andros Pharmaceuticals Co.,Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Andros Pharmaceuticals Co.,Ltd (6917). Check the MyAverix Finance app for the latest dividend data.

What sector is Andros Pharmaceuticals Co.,Ltd in?

Andros Pharmaceuticals Co.,Ltd (6917) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 6917 listed on?

6917 is listed on TWO.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)